LobbyingWalgreens lobbying by quarter
Walgreens's latest lobbying report covers Q2 2026, at $100K. The four quarters Q4 2025–Q3 2026 total $200K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Walgreens
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $200K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $110K | 2 |
| Q1 2023 | $110K | 2 |
| Q2 2023 | $110K | 2 |
| Q3 2023 | $110K | 2 |
| Q4 2023 | $110K | 2 |
| Q1 2024 | $50K | 2 |
| Q2 2024 | $50K | 2 |
| Q3 2024 | $50K | 2 |
| Q4 2024 | $50K | 2 |
| Q1 2025 | $50K | 2 |
| Q2 2025 | $50K | 2 |
| Q3 2025 | $50K | 2 |
| Q4 2025 | $50K | 2 |
| Q1 2026 | $50K | 2 |
| Q2 2026 | $100K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$315.3K · 15 reports
- Medicare and Medicaid$315.3K · 15 reports
- Taxation$112K · 7 reports
- Pharmacy$50K · 1 reports
- Labor, antitrust and workplace$33.3K · 2 reports
- Budget and appropriations$12K · 1 reports
- Copyright, patent and trademark$12K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES16 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| Forbes-Tate | $800K | 15 quarters |
| Guidepoststrategies | $300K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| EBONY MAJETTE | Staff Asst., Legis. Correspondent, Legis.Asst., Rep. Joseph Morelle; Staff Asst., Rep. Steny Hoyer | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Forbes-Tate | $50K |
| 07/19for Q2 | Guidepoststrategies | $50K |
| 04/20for Q1 | Guidepoststrategies | Under $5,000 |
| 04/19for Q1 | Forbes-Tate | $50K |
| 01/20for Q4 2025 | Guidepoststrategies | Under $5,000 |
| 01/19for Q4 2025 | Forbes-Tate | $50K |
| 25/10/20for Q3 2025 | Guidepoststrategies | Under $5,000 |
| 25/10/18for Q3 2025 | Forbes-Tate | $50K |
| 25/07/21for Q2 2025 | Guidepoststrategies | Under $5,000 |
| 25/07/18for Q2 2025 | Forbes-Tate | $50K |
| 25/04/21for Q1 2025 | Guidepoststrategies | Under $5,000 |
| 25/04/16for Q1 2025 | Forbes-Tate | $50K |
| 25/01/20for Q4 2024 | Guidepoststrategies | Under $5,000 |
| 25/01/19for Q4 2024 | Forbes-Tate | $50K |
| 24/10/21for Q3 2024 | Guidepoststrategies | Under $5,000 |
| 24/10/18for Q3 2024 | Forbes-Tate | $50K |
| 24/07/21for Q2 2024 | Guidepoststrategies | Under $5,000 |
| 24/07/14for Q2 2024 | Forbes-Tate | $50K |
| 24/04/22for Q1 2024 | Guidepoststrategies | Under $5,000 |
| 24/04/14for Q1 2024 | Forbes-Tate | $50K |